[current_date format=l,] [current_date]

Risk of Clade 1 Mpox Outbreaks Among Gay, Bisexual, and Other Men Who Have Sex With Men in the United States

55 views

By U.S. Centers for Disease Control and Prevention (CDC) To assess the impact among MSM of potential clade I mpox introduction into the U.S., CDC modeled varying levels of transmissibility and county-specific immunity. Modeling indicates as population-level immunity increased, the chances of a prolonged or large outbreak decreased. This report is one of two modeling studies exploring the potential spread of clade I mpox in the United States. This study explores the impacts of population-level immunity and transmissibility on sexual transmission of mpox among gay, bisexual, and other men who have sex with men. A separate study explores the impact of household and other non-sexual spread on number of cases and number of households infected in an outbreak. At a glance Clade I mpox is causing an ongoing outbreak in

By U.S. Centers for Disease Control and Prevention (CDC)

To assess the impact among MSM of potential clade I mpox introduction into the U.S., CDC modeled varying levels of transmissibility and county-specific immunity. Modeling indicates as population-level immunity increased, the chances of a prolonged or large outbreak decreased.

This report is one of two modeling studies exploring the potential spread of clade I mpox in the United States. This study explores the impacts of population-level immunity and transmissibility on sexual transmission of mpox among gay, bisexual, and other men who have sex with men. A separate study explores the impact of household and other non-sexual spread on number of cases and number of households infected in an outbreak.

At a glance
Clade I mpox is causing an ongoing outbreak in the Democratic Republic of the Congo (DRC). During the ongoing clade II mpox outbreak that began in 2022, the main transmission route was associated with sexual activity among certain gay, bisexual, and other men who have sex with men (MSM). As such, CDC modeled varying levels of transmissibility of clade I mpox and county-specific population-level immunity—from either previous infection or one or two doses of the JYNNEOS vaccine— among MSM in the United States to explore potential impacts of clade I mpox introduction to these sexual networks in the United States. Our modeling results indicate that:

  • Despite a higher presumed transmissibility of clade I mpox compared to clade II, in 13 U.S. counties, simulated clade I outbreaks among MSM were smaller than ongoing clade II outbreaks. The clade I outbreaks were likely smaller because of prior immunity from vaccination and previous infection, as well as the population’s related behavior change.
  • The size and duration of potential mpox outbreaks varied across individual counties due to differences in vaccination coverage and previous clade II mpox case rates, together referred to as population-level immunity.
  • As population-level immunity increased, the chances of a prolonged or large outbreak decreased. Therefore, CDC recommends all eligible people get vaccinated.

Background
In previous outbreaks in endemic African countries, clade I virus has caused a higher proportion of severe disease and been more transmissible than clade II within close-contact settings. To date, no cases of clade I mpox have been detected in the United States, despite wastewater monitoring for community detection and testing a high proportion of presumed mpox specimens with tests that can identify mpox by clade.

The current DRC outbreak of clade I mpox has likely resulted from transmission through several modes in different settings, including household, zoonotic, and sexual exposures. A 2024 outbreak in the Kamituga mining region in DRC has been associated with transactional sex, as 88% of hospitalized cases reported recent transactional sex. Additionally, health authorities reported six cases among MSM in a rural town in DRC in 2023. In a rapid risk assessment updated as of May 10, 2024, CDC assessed the risk posed by the clade I mpox outbreak in the DRC to the U.S. MSM population as low to moderate, higher than the risk posed to the general population.

Here, we use a dynamic, agent-based transmission model to explore in more detail the risk of prolonged sexual transmission among MSM in 13 counties in the United States if clade I monkeypox virus were to be introduced to this population. The 13 counties in this analysis were selected from 50 jurisdictions in the Ending the HIV Epidemic (EHE) Initiative to represent a range of population size and immunity profiles (see Methods for additional information). However, many of the EHE counties not included in our analysis likely are similar to the considered counties and would be expected to have similar probabilities of prolonged transmission.

Key findings
The county-level modeling results showing the size and duration of potential mpox outbreaks varied across individual counties due to differences in population-level immunity. For example, results indicated that outbreaks averaging more than 100 cases did not occur when population-level immunity from vaccination or previous infection was greater than 50% among MSM (Figure 1). Additionally, our simulation results showed that counties with higher population-level immunity had smaller outbreaks—defined as cumulative infections one year after introduction—and lower chance of prolonged transmission—defined as continued incident infections one year after introduction (Figure 2).

Our results suggest that high population-level immunity in a county, coupled with related behavior change, would lead to a much smaller mpox clade I outbreak among MSM compared to the ongoing mpox clade IIb outbreak. When comparing modeling results to number of confirmed diagnoses in the 2022 outbreak, only three of the 13 counties had more mpox diagnoses across all transmissibility scenarios modeled, and only two additional counties had more mpox diagnoses in the 20% more transmissible scenario modeled (data not shown to maintain anonymity). All five of these counties had estimated levels of population-level immunity below 25%.

Figure 1. Transmission of mpox among MSM in U.S. counties with a range of immunity profiles across three transmission scenarios: box plots of distribution of the cumulative number of infections expected within a year, following introduction of five individuals with mpox and with high levels of sexual activity. Transmission scenarios represent clade II (74.5% per-contact transmissibility), clade I (with 10% relative increased transmission over clade II), and clade I (with 20% relative increased transmission over clade II). (Photo:cdc.gov)
Figure 2. Transmission of mpox among MSM in U.S. counties with a range of immunity profiles across three transmission scenarios: probability of prolonged transmission after one year following introduction of five individuals with mpox with high levels of sexual activity. Transmission scenarios represent clade II, clade I (with 10% relative increased transmission over clade II), and clade I (with 20% relative increased transmission over clade II). (Photo:cdc.gov)

 

Among counties with population-level immunity lower than 50%, increases in immunity were correlated with lower probabilities of prolonged transmission among MSM for all three levels of transmissibility we analyzed (Figure 2). These results suggest that as the population-level immunity of a county increases, the probability of prolonged transmission decreases linearly, for all three levels of transmissibility we analyzed (Figure 2). In particular, counties with >50% population-level immunity had a <12% probability of prolonged transmission.

Public Health Considerations
Increasing population-level immunity through vaccination in counties can reduce both the number of infections as well as the chance of prolonged transmission of mpox. Vaccination is an important—yet underutilized—tool in preventing the spread of mpox. The Advisory Committee on Immunization Practices recommends people with potential risk of exposure to mpox receive two doses of the JYNNEOS vaccine. Despite this, only one in four of the approximately two million people recommended to receive the vaccine in the United States based on risk of exposure to clade II mpox have received both doses. JYNNEOS is also expected to protect against clade I mpox. CDC will continue to evaluate available data and assess the risk posed to MSM in the United States by the clade I mpox outbreak in DRC.

Tag

More on this topic

More Stories

SubscribeNewsletter@2x
Refreshing and Insights
at No Cost to You!

Cancel anytime

Latest Articles

Leave a Reply

Trending

Top Products

Contact us

Wherever & whenever you are,
we are here always.

The Middle Land

100 Wilshire Blvd., Suite 700 Santa Monica, CA 90401
Footer Contact

To Editor


Terms and Conditions

October, 2023

Using our website

You may use the The Middle Land website subject to the Terms and Conditions set out on this page. Visit this page regularly to check the latest Terms and Conditions. Access and use of this site constitutes your acceptance of the Terms and Conditions in-force at the time of use.

Intellectual property

Names, images and logos displayed on this site that identify The Middle Land are the intellectual property of New San Cai Inc. Copying any of this material is not permitted without prior written approval from the owner of the relevant intellectual property rights.

Requests for such approval should be directed to the competition committee.

Please provide details of your intended use of the relevant material and include your contact details including name, address, telephone number, fax number and email.

Linking policy

You do not have to ask permission to link directly to pages hosted on this website. However, we do not permit our pages to be loaded directly into frames on your website. Our pages must load into the user’s entire window.

The Middle Land is not responsible for the contents or reliability of any site to which it is hyperlinked and does not necessarily endorse the views expressed within them. Linking to or from this site should not be taken as endorsement of any kind. We cannot guarantee that these links will work all the time and have no control over the availability of the linked pages.

Submissions 

All information, data, text, graphics or any other materials whatsoever uploaded or transmitted by you is your sole responsibility. This means that you are entirely responsible for all content you upload, post, email or otherwise transmit to the The Middle Land website.

Virus protection

We make every effort to check and test material at all stages of production. It is always recommended to run an anti-virus program on all material downloaded from the Internet. We cannot accept any responsibility for any loss, disruption or damage to your data or computer system, which may occur while using material derived from this website.

Disclaimer

The website is provided ‘as is’, without any representation or endorsement made, and without warranty of any kind whether express or implied.

Your use of any information or materials on this website is entirely at your own risk, for which we shall not be liable. It is your responsibility to ensure any products, services or information available through this website meet your specific requirements.

We do not warrant the operation of this site will be uninterrupted or error free, that defects will be corrected, or that this site or the server that makes it available are free of viruses or represent the full functionality, accuracy and reliability of the materials. In no event will we be liable for any loss or damage including, without limitation, loss of profits, indirect or consequential loss or damage, or any loss or damages whatsoever arising from the use, or loss of data, arising out of – or in connection with – the use of this website.

Privacy & Cookie Policy

September 11, 2024

Last Updated: September 11, 2024

New San Cai Inc. (hereinafter “The Middle Land,” “we,” “us,” or “our”) owns and operates www.themiddleland.com, its affiliated websites and applications (our “Sites”), and provides related products, services, newsletters, and other offerings (together with the Sites, our “Services”) to art lovers and visitors around the world.

This Privacy Policy (the “Policy”) is intended to provide you with information on how we collect, use, and share your personal data. We process personal data from visitors of our Sites, users of our Services, readers or bloggers (collectively, “you” or “your”). Personal data is any information about you. This Policy also describes your choices regarding use, access, and correction of your personal information.

If after reading this Policy you have additional questions or would like further information, please email at middleland@protonmail.com.

PERSONAL DATA WE COLLECT AND HOW WE USE IT

We collect and process personal data only for lawful reasons, such as our legitimate business interests, your consent, or to fulfill our legal or contractual obligations.

Information You Provide to Us

Most of the information Join Talents collects is provided by you voluntarily while using our Services. We do not request highly sensitive data, such as health or medical information, racial or ethnic origin, political opinions, religious or philosophical beliefs, trade union membership, etc. and we ask that you refrain from sending us any such information.

Here are the types of personal data that you voluntarily provide to us:

  • Name, email address, and any other contact information that you provide by filling out your profile forms
  • Billing information, such as credit card number and billing address
  • Work or professional information, such as your company or job title
  • Unique identifiers, such as username or password
  • Demographic information, such as age, education, interests, and ZIP code
  • Details of transactions and preferences from your use of the Services
  • Correspondence with other users or business that you send through our Services, as well as correspondence sent to JoinTalents.com

As a registered users or customers, you may ask us to review or retrieve emails sent to your business. We will access these emails to provide these services for you.

We use the personal data you provide to us for the following business purposes:

  • Set up and administer your account
  • Provide and improve the Services, including displaying content based on your previous transactions and preferences
  • Answer your inquiries and provide customer service
  • Send you marketing communications about our Services, including our newsletters (please see the Your Rights/Opt Out section below for how to opt out of marketing communications)
  • Communicate with users who registered their accounts on our site
  • Prevent, discover, and investigate fraud, criminal activity, or violations of our Terms and Conditions
  • Administer contests and events you entered

Information Obtained from Third-Party Sources

We collect and publish biographical and other information about users, which we use to promote the articles and our bloggers  who use our sites. If you provide personal information about others, or if others give us your information, we will only use that information for the specific reason for which it was provided.

Information We Collect by Automated Means

Log Files

The site uses your IP address to help diagnose server problems, and to administer our website. We use your IP addresses to analyze trends and gather broad demographic information for aggregate use.

Every time you access our Site, some data is temporarily stored and processed in a log file, such as your IP addresses, the browser types, the operating systems, the recalled page, or the date and time of the recall. This data is only evaluated for statistical purposes, such as to help us diagnose problems with our servers, to administer our sites, or to improve our Services.

Do Not Track

Your browser or device may include “Do Not Track” functionality. Our information collection and disclosure practices, and the choices that we provide to customers, will continue to operate as described in this Privacy Policy, whether or not a “Do Not Track” signal is received.

HOW WE SHARE YOUR INFORMATION

We may share your personal data with third parties only in the ways that are described in this Privacy Policy. We do not sell, rent, or lease your personal data to third parties, and We does not transfer your personal data to third parties for their direct marketing purposes.

We may share your personal data with third parties as follows:

  • With service providers under contract to help provide the Services and assist us with our business operations (such as our direct marketing, payment processing, fraud investigations, bill collection, affiliate and rewards programs)
  • As required by law, such as to comply with a subpoena, or similar legal process, including to meet national security or law enforcement requirements
  • When we believe in good faith that disclosure is necessary to protect rights or safety, investigate fraud, or respond to a government request
  • With other users of the Services that you interact with to help you complete a transaction

There may be other instances where we share your personal data with third parties based on your consent.

HOW WE STORE AND SECURE YOUR INFORMATION

We retain your information for as long as your account is active or as needed to provide you Services. If you wish to cancel your account, please contact us middleland@protonmail.com. We will retain and use your personal data as necessary to comply with legal obligations, resolve disputes, and enforce our agreements.

All you and our data are stored in the server in the United States, we do not sales or transfer your personal data to the third party. All information you provide is stored on a secure server, and we generally accepted industry standards to protect the personal data we process both during transmission and once received.

YOUR RIGHTS/OPT OUT

You may correct, update, amend, delete/remove, or deactivate your account and personal data by making the change on your Blog on www.themiddleland.com or by emailing middleland@protonmail.com. We will respond to your request within a reasonable timeframe.

You may choose to stop receiving Join Talents newsletters or marketing emails at any time by following the unsubscribe instructions included in those communications, or you can email us at middleland@protonmail.com

LINKS TO OTHER WEBSITES

The Middle Land include links to other websites whose privacy practices may differ from that of ours. If you submit personal data to any of those sites, your information is governed by their privacy statements. We encourage you to carefully read the Privacy Policy of any website you visit.

NOTE TO PARENTS OR GUARDIANS

Our Services are not intended for use by children, and we do not knowingly or intentionally solicit data from or market to children under the age of 18. We reserve the right to delete the child’s information and the child’s registration on the Sites.

PRIVACY POLICY CHANGES

We may update this Privacy Policy to reflect changes to our personal data processing practices. If any material changes are made, we will notify you on the Sites prior to the change becoming effective. You are encouraged to periodically review this Policy.

HOW TO CONTACT US

If you have any questions about our Privacy Policy, please email middleland@protonmail.com

Article Submission


Logout

Are you sure? Do you want to logout of the account?

New Programs Added to Your Plan

March 2, 2023

The Michelin brothers created the guide, which included information like maps, car mechanics listings, hotels and petrol stations across France to spur demand.

The guide began to award stars to fine dining restaurants in 1926.

At first, they offered just one star, the concept was expanded in 1931 to include one, two and three stars. One star establishments represent a “very good restaurant in its category”. Two honour “excellent cooking, worth a detour” and three reward “exceptional cuisine, worth a

 

February 28, 2023        Hiring Journalists all hands apply

January 18, 2023          Hiring Journalists all hands apply

More

Leave a Reply

Forgot Password ?

Please enter your email id or user name to
recover your password

Roaster-JT
Thank you for your participation!
Back to Home
Roaster-JT
Thank you for your subscription!
Please check your email to activate your account.
Back to Home
Roaster-JT
Thank you for your participation!
Please check your email for the results.
Back to Home

Login to Vote!

Thank you for your participation,
please Log in or Sign up to Vote

Thank you for your Comment

Back to Home

Reply To:

New Programs Added to Your Plan


Login Now

123Sign in to your account